The Center for Advanced Molecular and Immunological Therapies will be a hub for precision medicine research, innovation and education in Phoenix.

As we attempt to get a grip on life post-pandemic, is acclimating to the new normal making everyone more short-tempered and irritable?

Resident students enrolled in the College of Medicine – Tucson and College of Medicine – Phoenix programs will see a 4.3% tuition increase, while nonresidents will see a 1% increase.

Some experts say giving doctors the flexibility to offer second COVID-19 boosters is reasonable, even if it’s not clear that extra doses are needed. This article shares what scientists recommend. Deepta Bhattacharya, PhD, professor of immunobiology at the College of Medicine – Tucson, is quoted.

The Center for Advanced Molecular and Immunological Therapies will provide staff, facilities, support and services to advance precision medicine.

Universities – and some providers themselves – are taking steps to close the gaps caused by a lack of nursing and medical education in hospice and palliative care.

Phoenix will soon be the home of the Center for Advanced Molecular and Immunological Therapies, a new University of Arizona Health Sciences center focused on developing biological therapies that stimulate or suppress the immune system to fight disease.

Biological changes after fire exposure may increase firefighters’ disease risk, according to Mel and Enid Zuckerman College of Public Health researchers.

A study led by researchers at the University of Arizona Mel and Enid Zukerman College of Public Health identified changes in the cellular mechanisms controlling gene expression, called epigenetics, that may contribute to an increased risk of diseases including cancer in firefighters.

The worldwide incidence of cutaneous melanoma is predicted to rise sharply over the next two decades, according to a report from the International Agency for Research on Cancer. In an editorial, Mavis Obeng-Kusi, MPharm, and Ivo Abraham, PhD, RN, from the Center for Health Outcomes and PharmacoEconomic Research at the R. Ken Coit College of Pharmacy, said the findings are "sobering," but may substantially underestimate the gravity of the problem in low- and middle-income countries.